Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study

Survival of patients with breast cancer can be prolonged by treatment with drugs, particularly new molecular-targeted drugs. However, these agents can be expensive and such treatments can be “an economic burden.” In this ongoing trial, we aim to assess the usefulness of ChemoCalc, a software package...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuba, Sayaka, Moriuchi, Hiroki, Yamanouchi, Kosho, Shibata, Kenichiro, Yano, Hiroshi, Oikawa, Masahiro, Maeda, Shigeto, Meng, Xiangyue, Morita, Michi, Hatachi, Toshiko, Otsubo, Ryota, Matsumoto, Megumi, Miyamoto, Junya, Kanetaka, Kengo, Taniguchi, Hideki, Nagayasu, Takeshi, Eguchi, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921475/
https://www.ncbi.nlm.nih.gov/pubmed/33718655
http://dx.doi.org/10.1016/j.conctc.2021.100739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921475/
https://www.ncbi.nlm.nih.gov/pubmed/33718655
http://dx.doi.org/10.1016/j.conctc.2021.100739

Ejemplares similares